WQ
ABBV icon

Wealth Quarterback’s AbbVie ABBV Stock Holding History

Wealth Quarterback’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Buy
1,261
+23
+2% +$4.95K 0.1% 129
2026
Q1 		$269K Sell
1,238
-25
-2% -$5.55K 0.11% 136
2025
Q4 		$289K Sell
1,263
-66
-5% -$15K 0.1% 128
2025
Q3 		$308K Buy
1,329
+7
+0.5% +$1.43K 0.12% 125
2025
Q2 		$245K Buy
1,322
+29
+2% +$5.39K 0.12% 123
2025
Q1 		$271K Sell
1,293
-229
-15% -$44.5K 0.15% 105
2024
Q4 		$270K Sell
1,522
-119
-7% -$21.9K 0.13% 98
2024
Q3 		$324K Sell
1,641
-401
-20% -$74.8K 0.17% 90
2024
Q2 		$350K Sell
2,042
-4,339
-68% -$719K 0.2% 81
2024
Q1 		$1.16M Sell
6,381
-1,899
-23% -$327K 0.65% 29
2023
Q4 		$1.28M Buy
8,280
+174
+2% +$25.4K 0.78% 21
2023
Q3 		$1.21M Sell
8,106
-502
-6% -$73.7K 1.05% 20
2023
Q2 		$1.16M Buy
8,608
+1,558
+22% +$228K 0.8% 22
2023
Q1 		$1.12M Sell
7,050
-170
-2% -$26K 0.95% 18
2022
Q4 		$1.17M Buy
7,220
+21
+0.3% +$3.22K 0.97% 20
2022
Q3 		$966K Buy
7,199
+2,851
+66% +$409K 1.03% 23
2022
Q2 		$666K Buy
+4,348
New +$664K 0.52% 42
2021
Q3 		$196K Sell
1,809
-327
-15% -$37.4K 0.13% 111
2021
Q2 		$241K Buy
+2,136
New +$241K 0.15% 102
2020
Q4 		$234K Sell
2,182
-504
-19% -$48.4K 0.19% 96
2020
Q3 		$264K Hold
2,686
– – 0.24% 91
2020
Q2 		$264K Buy
2,686
+245
+10% +$21.6K 0.24% 91
2020
Q1 		$186K Sell
2,441
-9,330
-79% -$795K 0.17% 110
2019
Q4 		$218K Buy
+11,771
New +$977K 0.19% 102

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealth Quarterback's ABBV Position: Q2 2026 in Review

Wealth Quarterback increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $4.95K and bringing the position to 1,261 shares worth $317K. The position accounts for 0.1% of the portfolio, ranked #129.

Wealth Quarterback first reported a position in ABBV in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.28M in Q4 2023. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealth Quarterback held 1,261 shares of AbbVie worth $317K as of Q2 2026.
  • Wealth Quarterback bought 23 AbbVie shares in Q2 2026, an estimated $4.95K.
  • AbbVie made up 0.1% of Wealth Quarterback's portfolio in Q2 2026, its #129 holding.
  • Wealth Quarterback first reported a position in AbbVie in Q4 2019 and has held it in 24 quarters since.
  • Wealth Quarterback's AbbVie position peaked at $1.28M in Q4 2023.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Quarterback's 13F filing for Q2 2026, filed 27 Jul 2026.